Lensar Inc (LNSR)

Mar 26, 2025, 1:20 PM EDT - 25 days ago

LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

ALC

Mar 3, 2025, 7:03 PM EST - 6 weeks ago

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 28, 2025, 1:05 PM EST - 7 weeks ago

LENSAR, Inc. (LNSR) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 7 weeks ago

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Feb 19, 2025, 12:00 PM EST - 2 months ago

LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025

Feb 5, 2025, 4:36 AM EST - 2 months ago

Medical Devices Firm Lensar Surges Ahead On Robotic Technology

Nov 26, 2024, 8:00 AM EST - 5 months ago

LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

Nov 9, 2024, 1:16 AM EST - 5 months ago

LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 5 months ago

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

Oct 31, 2024, 7:00 AM EDT - 6 months ago

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Oct 8, 2024, 8:00 AM EDT - 6 months ago

One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems

Sep 4, 2024, 8:00 AM EDT - 8 months ago

LENSAR to Participate in Two Upcoming Investor Conferences

Aug 10, 2024, 12:15 AM EDT - 9 months ago

LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 9 months ago

LENSAR Reports Second Quarter 2024 Results and Provides Business Update

Aug 7, 2024, 7:00 AM EDT - 9 months ago

LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union

Aug 1, 2024, 7:00 AM EDT - 9 months ago

LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

May 23, 2024, 8:00 AM EDT - 11 months ago

LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

May 11, 2024, 3:50 PM EDT - 1 year ago

LENSAR, Inc. (LNSR) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:00 AM EDT - 1 year ago

LENSAR Reports First Quarter 2024 Results and Provides Business Update

May 2, 2024, 8:00 AM EDT - 1 year ago

LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 4, 2024, 10:36 AM EST - 1 year ago

LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 7:00 AM EST - 1 year ago

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Feb 26, 2024, 8:00 AM EST - 1 year ago

LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

Nov 11, 2023, 12:32 PM EST - 1 year ago

LENSAR, Inc. (LNSR) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:00 AM EST - 1 year ago

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

Nov 2, 2023, 8:03 AM EDT - 1 year ago

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Aug 11, 2023, 6:04 PM EDT - 1 year ago

LENSAR, Inc. (LNSR) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 7:00 AM EDT - 1 year ago

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

Aug 2, 2023, 8:00 AM EDT - 1 year ago

LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

Jul 24, 2023, 7:00 AM EDT - 1 year ago

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

May 15, 2023, 10:25 AM EDT - 2 years ago

LENSAR, Inc. (LNSR) Q1 2023 Earnings Call Transcript

May 15, 2023, 7:00 AM EDT - 2 years ago

LENSAR Reports First Quarter 2023 Results and Provides Business Update

May 10, 2023, 8:00 AM EDT - 2 years ago

LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

Mar 16, 2023, 9:33 AM EDT - 2 years ago

LENSAR, Inc. (LNSR) Q4 2022 Earnings Call Transcript

Mar 16, 2023, 7:00 AM EDT - 2 years ago

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Mar 9, 2023, 8:00 AM EST - 2 years ago

LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

Feb 14, 2023, 7:00 AM EST - 2 years ago

LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

Nov 22, 2022, 8:00 AM EST - 2 years ago

LENSAR to Present at Two Upcoming Investor Conferences

Nov 12, 2022, 11:29 AM EST - 2 years ago

LENSAR, Inc. (LNSR) Q3 2022 Earnings Call Transcript

Nov 9, 2022, 7:00 AM EST - 2 years ago

LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

Nov 2, 2022, 8:00 AM EDT - 2 years ago

LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

Sep 8, 2022, 7:00 AM EDT - 2 years ago

LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

Aug 16, 2022, 7:00 AM EDT - 2 years ago

First Patients Treated with LENSAR's® ALLY™ Adaptive Cataract Treatment System

Aug 8, 2022, 10:59 AM EDT - 2 years ago

LENSAR, Inc. (LNSR) CEO Nicholas Curtis on Q2 2022 Results - Earnings Call Transcript

Aug 8, 2022, 7:00 AM EDT - 2 years ago

LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 1, 2022, 8:00 AM EDT - 2 years ago

LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022

Jun 13, 2022, 9:14 AM EDT - 3 years ago

Why Lensar Shares Are Trading Higher Today

Jun 13, 2022, 7:00 AM EDT - 3 years ago

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System